Ling Xi
Impact in
Papers in
-
- Circular RNAs in diseases 3
- Ubiquitin and proteasome pathways 3
- RNA Research and Splicing 2
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Ding Ma (9 shared papers)Jianfeng Zhou (7 shared papers)Kezhen Li (2 shared papers)Hui Wang (1 shared paper)Hui Shen (1 shared paper)Liming Wang (1 shared paper)Lan Yu (1 shared paper)Da Zhu (1 shared paper)
- Journals
- Nanomedicine (1 paper)Nature Communications (1 paper)Theranostics (1 paper)OncoTargets and Therapy (1 paper)Cancers (1 paper)
- Partner nations
- ChinaUnited StatesTürkiye
In The Last Decade
Ling Xi
28 papers receiving 746 citations
Peers
Comparison fields: 5 of 86
- Business and International Management 20
- Cancer Research 121
- Molecular Biology 506
- Oncology 166
- Immunology 94
Countries citing papers authored by Ling Xi
This map shows the geographic impact of Ling Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xi more than expected).
Fields of papers citing papers by Ling Xi
This network shows the impact of papers produced by Ling Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xi. The network helps show where Ling Xi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Xi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 165 | |
| 2 | 2018 | 90 | |
| 3 | 2016 | 59 | |
| 4 | 2017 | 43 | |
| 5 | 2008 | 42 | |
| 6 | 2007 | 40 | |
| 7 | 2022 | 40 | |
| 8 | 2012 | 39 | |
| 9 | 2007 | 33 | |
| 10 | 2005 | 25 | |
| 11 | 2021 | 21 | |
| 12 | 2019 | 21 | |
| 13 | 2013 | 20 | |
| 14 | 2023 | 19 | |
| 15 | 2019 | 18 | |
| 16 | 2012 | 18 | |
| 17 | 2021 | 17 | |
| 18 | 2017 | 15 | |
| 19 | 2022 | 6 | |
| 20 | 2019 | 5 |
About Ling Xi
Ling Xi is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Epidemiology, having authored 32 papers that have together received 753 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer Research and Treatments (3 papers), Circular RNAs in diseases (3 papers), Ferroptosis and cancer prognosis (3 papers), Ubiquitin and proteasome pathways (3 papers), Nanoplatforms for cancer theranostics (2 papers), RNA Research and Splicing (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Business and International Management (20 citations), Cancer Research (121 citations), Molecular Biology (506 citations), Oncology (166 citations) and Immunology (94 citations). Ling Xi has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Ding Ma, Jianfeng Zhou, Kezhen Li, Hui Wang, Hui Shen, Liming Wang, Lan Yu, Da Zhu, Wencheng Ding and Dan He. Their work appears in journals such as Nanomedicine, Nature Communications, Theranostics, OncoTargets and Therapy and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.